Thank you to our speakers, sponsors, and delegates who joined us in 2024 for the summit!
If you are interested in the 2025 event, please get in touch at info@hansonwade.com.
What Happened at the 3rd Next Generation Lipid-Based Nanoparticles Devliery Summit?
We Unlocked Targeted Lipid Vehicle Therapies with Precision in Cell, Tissue & Organ Specificity
Initially sparked by COVID-19, renewed interest in lipid-based systems for delivery has now evolved. With an escalating clinical demand and the chance to commercialize lipid-based nanoparticles for novel applications and tissue delivery, the spotlight remains on delivery as the key to achieving clinical and commercial success, unlocking new therapeutic horizons.
The 3rd Next Generation Lipid-Based Nanoparticles Delivery Summit was the only event dedicated entirely to lipid-based nanoparticle delivery, where we brought together 120+ experts in LNP non-clinical, delivery, particle engineering, and formulation from the likes of Teressa, Sanofi, MediciBio, CureVac. Together, we were on a mission to revolutionize drug delivery, conquering the intricate challenges of lipid-based nanoparticle delivery beyond RNAs and extending cargos to destinations beyond the liver.
Across 3 days of carefully curated content, we experienced the cutting edge of innovation as we refined dosing strategies and minimized off-target effects to enhance therapeutic efficacy while reducing toxicity. We stayed ahead of the curve with insights into device-formulation compatibility for cutting-edge routes of administration, tailoring delivery methods to specific targets of interest. We unlocked the potential of LNPs to reach challenging tissues, customized to suit unique therapeutic application.
View the 2024 Agenda Now:
Our 2024 Partners:
Other Events In the LNP Development Series:
